Hostname: page-component-7b7567c8c-tnkh4 Total loading time: 0 Render date: 2026-11-17T09:11:24.022Z Has data issue: false hasContentIssue false

148 Accelerating academic innovation: Comparative insights from the translational case studies in commercialization working group

Published online by Cambridge University Press:  08 May 2026

Shawn Gomez
Affiliation:
University of Massachusetts Medical School
Aditi Martin
Affiliation:
Oregon Health & Science University
Jonathan Jubera
Affiliation:
Oregon Health & Science University
Molly Wasko
Affiliation:
Oregon Health & Science University
Sandra Wells
Affiliation:
University of Minnesota
Debra Diaz Grandos
Affiliation:
Virginia Commonwealth University
Sheela Dominguez
Affiliation:
University of Miami
Denise Dunlap
Affiliation:
University of Massachusetts MED SCH Worcester
Gallya Gannot
Affiliation:
NCATS/NIH
Paula Leon
Affiliation:
University of North Carolina Chapel Hill
Susan Pusek
Affiliation:
University of North Carolina Chapel Hill
Meena Rajagopal
Affiliation:
NCATS/NIH
Suhrud Rajguru
Affiliation:
University of Miami School of Medicine
Anna Thornton Matos
Affiliation:
Case Western Reserve University
Kris Bough
Affiliation:
NCATS/NIH
Andrew Kant
Affiliation:
University of North Carolina Chapel Hill
Erin Carey
Affiliation:
University of North Carolina Chapel Hill
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Objectives/Goals: To generate actionable insights into the commercialization process in academic translational science by using comparative case studies to identify strategies, success factors, and challenges across CTSA hubs, informing best practices for innovators and institutions. Methods/Study Population: We will employ a comparative case study approach, engaging 11 CTSA hubs to document two or more product-specific commercialization case studies, including at least one successful and one unsuccessful example. To ensure the comprehensiveness and consistency of data collection and analysis across cases, a standardized framework developed by the TCSC WG is followed by all participating hubs for both quantitative data (e.g., milestones, funding) and qualitative insights (stakeholder interviews). Coding and downstream cross-case analysis is leveraged to identify unifying themes and discriminating factors in commercialization strategies and associations with success and failure. Results/Anticipated Results: We aim to identify patterns, barriers, and catalysts in academic commercialization, defining key resources along with effective practices and strategies. Findings will clarify the role of CTSA hubs and their collaboration with institutional partners such as Technology Transfer. Results will highlight best practices in IP management, funding, team dynamics, partnerships, and regulatory navigation. A comparative analysis across CTSA hubs will yield a case study repository, cross-case report, educational materials, and a peer-reviewed publication. Collectively, we expect findings to provide practical guidance to NCATS and academic institutions for accelerating biomedical innovation. Discussion/Significance of Impact: This study fills a critical gap by providing real-world, comparative insights into the commercialization process within academic medicine. Outcomes will support CTSA hubs, healthcare systems, innovators, and policymakers in improving translational efficiency and maximizing innovation impact.

Information

Type
Contemporary Research Challenges
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - NCCreative Common License - ND
This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
Copyright
© The Author(s), 2026. The Association for Clinical and Translational Science